Literature DB >> 32930869

Phenotypic diversity in ALS and the role of poly-conformational protein misfolding.

Jacob I Ayers1, David R Borchelt2.   

Abstract

In many types of familial amyotrophic lateral sclerosis (fALS), mutations cause proteins to gain toxic properties that mediate neurodegenerative processes. It is becoming increasingly clear that the proteins involved in ALS, and those responsible for a host of other neurodegenerative diseases, share many characteristics with a growing number of prion diseases. ALS is a heterogenous disease in which the majority of cases are sporadic in their etiology. Studies investigating the inherited forms of the disease are now beginning to provide evidence that some of this heterogeneity may be due to the existence of distinct conformations that ALS-linked proteins can adopt to produce the equivalent of prion strains. In this review, we discuss the in vitro and in vivo evidence that has been generated to better understand the characteristics of these proteins and how their tertiary structure may impact the disease phenotype.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Prion; Strains; Superoxide dismutase-1; TDP-43

Mesh:

Substances:

Year:  2020        PMID: 32930869      PMCID: PMC7956917          DOI: 10.1007/s00401-020-02222-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


  117 in total

1.  Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.

Authors:  Julio A Alfieri; Natalia S Pino; Lionel M Igaz
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Neurotoxic effects of TDP-43 overexpression in C. elegans.

Authors:  Peter E A Ash; Yong-Jie Zhang; Christine M Roberts; Tassa Saldi; Harald Hutter; Emanuele Buratti; Leonard Petrucelli; Christopher D Link
Journal:  Hum Mol Genet       Date:  2010-06-08       Impact factor: 6.150

3.  Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.

Authors:  Ryuichiro Atarashi; Roger A Moore; Valerie L Sim; Andrew G Hughson; David W Dorward; Henry A Onwubiko; Suzette A Priola; Byron Caughey
Journal:  Nat Methods       Date:  2007-07-22       Impact factor: 28.547

Review 4.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

5.  Experimental transmissibility of mutant SOD1 motor neuron disease.

Authors:  Jacob I Ayers; Susan Fromholt; Morgan Koch; Adam DeBosier; Ben McMahon; Guilian Xu; David R Borchelt
Journal:  Acta Neuropathol       Date:  2014-09-28       Impact factor: 17.088

6.  The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.

Authors:  W Michael Babinchak; Raza Haider; Benjamin K Dumm; Prottusha Sarkar; Krystyna Surewicz; Jin-Kyu Choi; Witold K Surewicz
Journal:  J Biol Chem       Date:  2019-02-27       Impact factor: 5.157

7.  Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.

Authors:  Jacob I Ayers; Jeffrey Diamond; Adriana Sari; Susan Fromholt; Ahmad Galaleldeen; Lyle W Ostrow; Jonathan D Glass; P John Hart; David R Borchelt
Journal:  Acta Neuropathol       Date:  2016-10-04       Impact factor: 17.088

8.  Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.

Authors:  Jacob I Ayers; Susan E Fromholt; Veronica M O'Neal; Jeffrey H Diamond; David R Borchelt
Journal:  Acta Neuropathol       Date:  2015-12-09       Impact factor: 17.088

9.  The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease.

Authors:  Jacob I Ayers; Charles R Schutt; Ronald A Shikiya; Adriano Aguzzi; Anthony E Kincaid; Jason C Bartz
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

10.  Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.

Authors:  Jacob I Ayers; Guilian Xu; Olga Pletnikova; Juan C Troncoso; P John Hart; David R Borchelt
Journal:  Acta Neuropathol Commun       Date:  2014-05-14       Impact factor: 7.801

View more
  4 in total

1.  Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion.

Authors:  Li-Qiang Wang; Yeyang Ma; Han-Ye Yuan; Kun Zhao; Mu-Ya Zhang; Qiang Wang; Xi Huang; Wen-Chang Xu; Bin Dai; Jie Chen; Dan Li; Delin Zhang; Zhengzhi Wang; Liangyu Zou; Ping Yin; Cong Liu; Yi Liang
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

2.  Identification of Molecular Correlations Between DHRS4 and Progressive Neurodegeneration in Amyotrophic Lateral Sclerosis By Gene Co-Expression Network Analysis.

Authors:  Shu Li; Yu Zhu; Caihui Wei; Cheng Li; Wenzhi Chen; Shishi Jiang; Dongxiang Yuan; Renshi Xu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 3.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

4.  Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice.

Authors:  Isil Keskin; Elaheh Ekhtiari Bidhendi; Matthew Marklund; Peter M Andersen; Thomas Brännström; Stefan L Marklund; Ulrika Nordström
Journal:  Acta Neuropathol Commun       Date:  2021-06-22       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.